BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15070098)

  • 1. ATP-dependent transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) and its xenobiotic taurine conjugate (Z-335-Tau) by rat bile canalicular membrane vesicles.
    Kawabata Y; Kamada E; Furuta S; Takei M; Kurimoto T; Okudaira K; Nishigaki R
    Pharm Res; 2004 Mar; 21(3):467-75. PubMed ID: 15070098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats.
    Kawabata Y; Nakamura H; Kamada E; Furuta S; Shinozaki Y; Kurimoto T; Nishigaki R
    J Pharm Sci; 2003 Jan; 92(1):67-76. PubMed ID: 12486683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
    Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
    Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
    Yamazaki M; Kobayashi K; Sugiyama Y
    Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M; Kobayashi K; Sugiyama Y
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-mediated active transport of a novel thromboxane A(2) receptor antagonist [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into rat liver.
    Kawabata Y; Furuta S; Shinozaki Y; Kurimoto T; Nishigaki R
    Drug Metab Dispos; 2002 May; 30(5):498-504. PubMed ID: 11950778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
    Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.
    Akita H; Suzuki H; Ito K; Kinoshita S; Sato N; Takikawa H; Sugiyama Y
    Biochim Biophys Acta; 2001 Mar; 1511(1):7-16. PubMed ID: 11248200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.
    Akhteruzzaman S; Kato Y; Hisaka A; Sugiyama Y
    J Pharmacol Exp Ther; 1999 Feb; 288(2):575-81. PubMed ID: 9918561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
    Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
    Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
    Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
    Hirouchi M; Suzuki H; Sugiyama Y
    Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.
    Masuda M; I'izuka Y; Yamazaki M; Nishigaki R; Kato Y; Ni'inuma K; Suzuki H; Sugiyama Y
    Cancer Res; 1997 Aug; 57(16):3506-10. PubMed ID: 9270020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
    Sasabe H; Kato Y; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary transport of a nonpeptidic endothelin antagonist, (+)-(5S,6R,7R)-2-butyl-7-[2((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3,4-methylenedioxyphenyl) cyclopentenol[1,2-b]pyridine-6-carboxylic acid: uptake by isolated rat hepatocytes and canalicular membrane vesicles.
    Kobayashi N; Tani T; Hisaka A; Hara K; Yasumori T
    Pharm Res; 2003 Jan; 20(1):89-95. PubMed ID: 12608541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
    Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2.
    Morikawa A; Goto Y; Suzuki H; Hirohashi T; Sugiyama Y
    Pharm Res; 2000 May; 17(5):546-52. PubMed ID: 10888306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
    Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
    Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane.
    Shilling AD; Azam F; Kao J; Leung L
    J Pharmacol Toxicol Methods; 2006; 53(3):186-97. PubMed ID: 16176877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.